Surgical treatment of dystonia

Rubens Gisbert Cury1,2, Suneil Kumar Kalia3, Binit Bipin Shah4

  • 1a Service de Neurologie, Centre Hospitalier Universitaire de Grenoble , Université Grenoble Alpes , Grenoble , France.

Abstract

Insights

Deep brain stimulation (DBS) offers safe and effective surgical treatment for isolated dystonia, particularly benefiting younger patients with shorter disease duration. Further research is needed to identify optimal surgical candidates for acquired and combined dystonia types.

Area of Science:

  • Neurology
  • Neurosurgery
  • Movement Disorders

Background:

  • Dystonia treatment requires individualized approaches, with surgery being a key option for medically refractory cases.
  • Surgical targets and predictors of benefit for dystonia remain areas of ongoing investigation and debate.

Purpose of the Study:

  • To review the current evidence on surgical interventions for dystonia, focusing on deep brain stimulation (DBS) and ablative procedures.
  • To discuss the safety, efficacy, and patient selection criteria for various surgical options in dystonia management.

Main Methods:

  • Systematic review of clinical trials and existing literature on surgical treatments for dystonia.
  • Analysis of data regarding DBS targets (globus pallidus internus, subthalamic nucleus) and ablative techniques (pallidotomy, thalamotomy).

Main Results:

  • Deep brain stimulation (DBS) is proven safe and effective for inherited and idiopathic isolated dystonia, with the globus pallidus internus (GPi) as the most supported target.
  • Younger patients with shorter disease duration show greater benefit from DBS.
  • Pallidotomy and thalamotomy are viable options for select patients, and MRI-guided focused ultrasound presents emerging possibilities.

Conclusions:

  • Globus pallidus internus deep brain stimulation (GPi-DBS) is a safe and effective treatment for isolated dystonia, recommended when quality of life is significantly impacted.
  • Further research is essential to identify optimal surgical candidates for acquired and combined dystonias.
  • Advancements in understanding dystonia pathophysiology and surgical technology will refine treatment strategies and optimize outcomes.

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
975
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
440
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.7K